Device typeAlpha-fetoprotein-L3 fraction (AFP-L3) IVD, kit, fluorescent immunoassay: A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein-L3 fraction (AFP-L3) in a clinical specimen, using a fluorescent immunoassay method. It is typically used to aid in the diagnosis of hepatocellular carcinoma (HCC).
FDA categoryTest, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment
Device ID14987481164465
Catalog number997-61501
AvailabilityPrescription
Single useYes
MRI safetyLabeling does not contain MRI Safety Information